| Jul 8, 2014
| 1:49 PM
Apple's done it. Herbalife has done it. Pfizer wanted to do it. What could be wrong with a corporate maneuver eyed by these fine, upstanding American corporations--and nearly 50 others in the last decade?
The subject is "inversions," the catch-all...
| Aug 25, 2014
| 3:16 PM
U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation.
If approved by the...
| Jul 29, 2014
| 10:20 AM
Pfizer Inc on Tuesday left investors guessing whether it would renew its pursuit of its British rival, AstraZeneca, but said it was considering other deals.
The largest U.S. drug maker reported higher-than-expected second-quarter revenue, helped by...
| Mar 19, 2013
Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines.
Today, as the world confronts the crisis of antibiotic resistance, the industry...
| Jul 12, 2013
| 2:33 PM
Wedding date: May 18, 2013
Her story: Courtney Munzer, 24, grew up in Middletown, Del. She is a pediatric nurse at Children's Hospital of The King's Daughters in Norfolk, Va. Her mother, Deborah Munzer, works at AstraZeneca, a biopharmaceutical company,...
| Jan 8, 2014
| 6:45 PM
The Food and Drug Administration on Wednesday approved U.S. marketing of the drug dapagliflozin, the second of a new class of medications that aim to improve glycemic control in patients with Type 2 diabetes. The drug will be marketed under the name...
| Nov 14, 2013
| 4:38 PM
Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...
| Oct 1, 2013
| 8:33 AM
Merck & Co., the second-largest drug maker by sales, said Tuesday it will lay off 8,500 employees in a strategy overhaul to revamp its research and development efforts.
That's on top of a previous announcement that the Whitehouse Station, N.J.-based...
| Sep 26, 2011
| 4:05 AM
CHICAGO (Reuters) - Genetic differences could explain why some 40 percent of people with asthma do not respond to inhaled steroids used to achieve long-term asthma control.
U.S. researchers have found that asthma patients who inherited two copies of a...
| Sep 27, 2011
At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms.
Doctors in the...
| Oct 25, 2011
| 2:21 PM
NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...